Exousia Bio, Inc.
LMMY · OTCMCIK 1939937fmd_1FV59B9GFNPZ0FZVWBF7CZH1MFServices · Services-Educational ServicesTemplate: Standard
Coverage: Jun 01, 2021 to Feb 28, 2026, 16 periods
Latest annual · FY2025
Millions- Total revenues
- 0
- Gross profit
- (0)
- Operating income
- (0)
- Net income
- 0
Latest quarter · Q3 FY2026
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- 0
- Net income
- 0
- Free cash flow
- 0
Exousia Bio, Inc. (LMMY) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $3,750 | $11,500 | -67.4% | 10-K 2025-10-17 · proof |
| Gross profit | -$3,501 | $1,833 | -291% | 10-K 2025-10-17 · proof |
| Operating income | -$35,344 | -$26,243 | 10-K 2025-10-17 · proof | |
| Net income | $51,395 | -$25,807 | 10-K 2025-10-17 · proof | |
| Cash from operating activities | -$4,528 | -$12,484 | 10-K 2025-10-17 · proof | |
| Total assets | $0 | $27,453 | -100% | 10-K 2025-10-17 · proof |
| Total liabilities | $0 | $82,348 | -100% | 10-K 2025-10-17 · proof |
| Cash and cash equivalents | $0 | $1,028 | -100% | 10-K 2025-10-17 · proof |
- What was Exousia Bio, Inc. (LMMY)'s revenue in fiscal 2025?
- Exousia Bio, Inc. (LMMY) reported revenue of $3,750 for fiscal 2025 (the year ended May 31, 2025), against $11,500 the year before (-67.4%). Source: the 10-K filed with the SEC on Oct 17, 2025. SEC
- What was Exousia Bio, Inc. (LMMY)'s gross profit in fiscal 2025?
- Exousia Bio, Inc. (LMMY) reported gross profit of -$3,501 for fiscal 2025 (the year ended May 31, 2025), against $1,833 the year before (-291%). Source: the 10-K filed with the SEC on Oct 17, 2025. SEC
- What was Exousia Bio, Inc. (LMMY)'s operating income in fiscal 2025?
- Exousia Bio, Inc. (LMMY) reported operating income of -$35,344 for fiscal 2025 (the year ended May 31, 2025), against -$26,243 the year before. Source: the 10-K filed with the SEC on Oct 17, 2025. SEC
- What was Exousia Bio, Inc. (LMMY)'s net income in fiscal 2025?
- Exousia Bio, Inc. (LMMY) reported net income of $51,395 for fiscal 2025 (the year ended May 31, 2025), against -$25,807 the year before. Source: the 10-K filed with the SEC on Oct 17, 2025. SEC
- What was Exousia Bio, Inc. (LMMY)'s cash from operating activities in fiscal 2025?
- Exousia Bio, Inc. (LMMY) reported cash from operating activities of -$4,528 for fiscal 2025 (the year ended May 31, 2025), against -$12,484 the year before. Source: the 10-K filed with the SEC on Oct 17, 2025. SEC
- What are Exousia Bio, Inc. (LMMY)'s total assets?
- As of May 31, 2025, Exousia Bio, Inc. (LMMY) reported total assets of $0, against $27,453 a year earlier (-100%). Source: the 10-K filed with the SEC on Oct 17, 2025. SEC
- What are Exousia Bio, Inc. (LMMY)'s total liabilities?
- As of May 31, 2025, Exousia Bio, Inc. (LMMY) reported total liabilities of $0, against $82,348 a year earlier (-100%). Source: the 10-K filed with the SEC on Oct 17, 2025. SEC
- What are Exousia Bio, Inc. (LMMY)'s cash and cash equivalents?
- As of May 31, 2025, Exousia Bio, Inc. (LMMY) reported cash and cash equivalents of $0, against $1,028 a year earlier (-100%). Source: the 10-K filed with the SEC on Oct 17, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:LMMY&period_type=annual&limit=5"Information only, not investment advice.